TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Assessment of physical function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maximum Concentration (Cmax) of Blosozumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Curve of Blosozumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anti-Xa activity value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects Achieving Target Systolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of autoimmune conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Presentation of Primary Tumor to Metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Bone mineral density loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: BMI ≥ 95th Percentile for Age and Sex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Visual Analogue Scales for pain (PVAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caries likelihood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptomatic recurrent venous thromboembolism
Endpoint domain: Adverse events/effects
Primary endpoint: serious bleedings
Endpoint domain: Adverse events/effects
Primary endpoint: Taste and Overall Acceptability Profile
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Demonstration of volunteer preference for a HPTs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Demonstration of volunteer readability of HPTs
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Demonstration of consumer preference for a HPT
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent Change in Lumbar Spine Bone Mineral Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Advanced Liver Fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Changes in doctor behavior regarding diagnostic tests and antibiotic prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of invasive aspergillosis
Endpoint domain: Adverse events/effects
Primary endpoint: Patient Mortality Rates
Endpoint domain: Mortality/survival
Primary endpoint: Dyspnea rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tear Lipid Composition Profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the NPF Psoriasis Score of Plaques
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean Change in Headache Impact Test (HIT-6)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Mean Change in MDS-UPDRS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in PROMIS Cognitive Functioning Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: ocular and systemic adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Vitality Subscale Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Survival without needs of ventilator utilization
Endpoint domain: Mortality/survival
Primary endpoint: WHO progression scale ≥6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve from time zero to last sampling time [AUC(0-t)]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequencies of positive urine drug screens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Breathalyzer alcohol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Patient Health Questionnaire (PHQ) 9-items
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Generalized Anxiety Disorder (GAD) 7-item Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: % patients with RNA-HCV < 50 UI/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Quality of initial care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: 1 year progression free survival
Endpoint domain: Mortality/survival
Primary endpoint: Diagnosis of joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Inscription on kidney transplantation waiting list
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Frequency of aerosol therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration of Carfilzomib (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Maximum Observed Plasma Concentration of Carfilzomib (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom From Progression (FFP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient knowledge regarding treatment options
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decrease in total serum bilirubin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute lymphocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Treatment of anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inappropriate ICD Therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Positive Airway Pressure Adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal coronary z score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Collagen Content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elastin Content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post operative bruising
Endpoint domain: Adverse events/effects
Primary endpoint: Complication rate of the reconstructive procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of bone gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite measure based on the Bakas Caregiving Outcomes Scale and the Brief Symptom Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: changes in genes related to mitochondrial and lipid metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: American Heart Association MyLifeCheck (Simple 7) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Confirmed cases of COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Percent Change in Myofiber Cross Sectional Area (CSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Myofibrillar Protein Synthesis Rate (MyoKsyn)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Delay in plasma triglyceride clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Delay in chylomicron clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ulcer-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Change on Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Safety and Tolerability of Modified Low Carbohydrate Diet
Endpoint domain: Adverse events/effects
Primary endpoint: Complications (morbidity score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TimeLine Follow Back
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: score at the RAADS-R scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Success rate of Investigator's Global Assessment (IGA)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Type of access to care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Virologically-confirmed dengue cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Suspected dengue case as per clinical diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Qualitative increase in radiotracer uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of Vitamin D deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety data of the procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical performance of the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Doripenem concentrations in CSF and plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of ABSIS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of axial intraocular lens position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Perinatal SARS-CoV-2 infection
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline in VAS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: VL suppression rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Drug Resistance Mutations (DRMs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIF-1a and VEGF expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bowel function index (BFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mayo Score Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of solid food intake by mouth per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in abdominal pain as assessed by patient reported pain on scale 1-10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproducibility of Young's modulus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Quality of life in patients with Parkinson's disease
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from Baseline Quality of life in family carers
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SIBO diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Self-Effectiveness-Efficacy Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quadriceps central activation ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quadriceps torque production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fidelity of the intervention using a composite fidelity score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cost per safe ventilation day
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pathway Acceptability measured using the Theoretical Framework of Acceptability (TFA)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of children identified with mental health services need
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Undetectable Viral Loads
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cyclical Change in Suicidal Ideation Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensory index effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: toxicity of treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Number of clinically significant adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Students' Organizational Functioning - Teacher Report
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Students' Organizational Functioning - Parent Report
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: efficacy of therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary pH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of IS in subjects aged < 12 months
Endpoint domain: Mortality/survival
Primary endpoint: urinary retention rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: maximum International Prostate Symptom Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibodies against SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Energy intake during fast food feedings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Real life impairment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Alpha-synuclein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ICH volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite measure of intrapartum and neonatal death and serious morbidity of the second twin
Endpoint domain: Mortality/survival
Primary endpoint: Area under curve (AUC) in detection performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Quality of Life (QoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Participants With Adverse Events by Grade
Endpoint domain: Adverse events/effects
Primary endpoint: Mean variation of the BASFI score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Efficacy of Movicol in treating faecal impaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Safety of Movicol
Endpoint domain: Adverse events/effects
Primary endpoint: sputum cytology results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline in pain threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in pain perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of adverse events and adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: HCV clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete regression of NHL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Distribution of AST2818 in whole blood and plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Types of adverse events assessed by CTCAE v5.0
Endpoint domain: Adverse events/effects
Primary endpoint: Timed 25 Foot Walk Test (T25FWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Keloid progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Self-Reported Intentions to Adhere to Clinician Recommendations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Actual Adherence to Clinician Recommendations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Client Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: clinical recovery time (TTCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Se-osteopontin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central Apnea-Hypopnea Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Immunoreactive nerve fibers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Psychophysiological changes in skin conductance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor PD-L1 by IHC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Density of peri-tumoral and intra-tumoral CD3, CD4 and CD8-positive lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum pro-inflammatory cytokines and chemokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Estimation of the proportion and relative frequency of treatment-emergent AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of hyponatraemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Assessment of renal toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Airway Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hearing related quality of life (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of > Grade 2 hearing loss
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of > Grade 1 hearing loss
Endpoint domain: Adverse events/effects
Primary endpoint: salivary cortisol/cortisone ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Patient Health Questionnaire -9
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Percent Correct Score for the Treasure Hunt Task (THT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Continuous Abstinence at 12 Weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Change in Freezing of Gait Questionnaire Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of patients with more than 1 grade improvement in Hughes Functional Grade
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Regressed change from baseline in expectations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Regressed change from baseline in prognostic pessimism
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean difference on platelet count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Biting Force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICS outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: abnormal retinal geometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACR Pediatric 30
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of disease-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Percent of patients experiencing treatment delays or discontinuation due to drug-related AEs
Endpoint domain: Adverse events/effects
Primary endpoint: post-operative bleeding complication
Endpoint domain: Adverse events/effects
Primary endpoint: Immunophenotypic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ratio of Liver Choline Pool Size by Isotope Dilution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Liver Fat Content Based on CAP Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: feasibility and safety of treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Improved Albuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Absolute Change in the Simplified Disease Activity Index (SDAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Teen and sibling alcohol use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Difference in gestational age assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change in tongue surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Abnormal Laboratory Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Averaged Maximum Flow Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Effectiveness of imatinib in combination with daunorubicine and cytarabine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability of imatinib in combination with daunorubicine and cytarabine
Endpoint domain: Adverse events/effects
Primary endpoint: Forced vital capacity in 1 second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: IVF outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes